Keyphrases
T Cells
100%
Antitumor
100%
Tumor-specific
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
NCR1
100%
Tumor
60%
Natural Killer Cells
40%
Tumor Recognition
40%
Cancer Treatment
20%
Extracellular Domain
20%
Activation Markers
20%
Immunotherapeutics
20%
Oncogene
20%
Tumor Regression
20%
Receptor-mediated
20%
Malignancy
20%
Leukemia Patients
20%
Recognition Ability
20%
Cell-derived
20%
Lung
20%
Adoptive Transfer
20%
Antitumor Activity
20%
Genetic Modification
20%
Natural Killer
20%
Pancreatic Cancer
20%
Efficient Recognition
20%
Melanoma Patients
20%
Receptor-based
20%
Surface Activation
20%
Tumor Cytotoxicity
20%
Multiple Signalling
20%
GTP-binding Proteins
20%
Cervical Carcinoma
20%
RalA
20%
RalB
20%
Gene-modified T Cells
20%
NKp46
20%
Leukemia Cancer
20%
Anti-tumor Response
20%
RAS-like
20%
Medicine and Dentistry
Neoplasm
100%
T Cell
100%
Receptor
100%
T Lymphocyte
40%
Leukemia
40%
Natural Killer Cell
40%
In Vitro
20%
Malignant Neoplasm
20%
Cancer Treatment
20%
Nodular Melanoma
20%
Antineoplastic Activity
20%
Upregulation
20%
Tumor Regression
20%
Cancer
20%
Primary Tumor
20%
Target Cell
20%
Guanine Nucleotide Binding Protein
20%
Pancreas Cancer
20%
Proto Oncogene
20%
Adoptive Transfer
20%
Ras
20%
Uterine Cervix Carcinoma
20%
Cytotoxicity
20%
Biochemistry, Genetics and Molecular Biology
NCR1
100%
T Cell
100%
Eicosanoid Receptor
100%
Natural Killer Cell
33%
Surface Property
16%
GTP Binding Protein
16%
Coculture
16%
Antineoplastic Activity
16%
Upregulation
16%
DNA Modification
16%
Proto Oncogene
16%
Cytotoxicity
16%
Target Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Neoplasm
100%
Leukemia
40%
Malignant Neoplasm
40%
Cytotoxicity
20%
Antitumor Activity
20%
Guanine Nucleotide Binding Protein
20%
Melanoma
20%
Tumor Regression
20%
Pancreas Cancer
20%
Uterine Cervix Carcinoma
20%
Primary Tumor
20%
Immunology and Microbiology
NCR1
100%
T Cell
100%
Natural Killer Cell
33%
Surface Property
16%
Cytotoxicity
16%
Coculture
16%
Antineoplastic Activity
16%
Upregulation
16%
Target Cell
16%
Proto Oncogene
16%
DNA Modification
16%
Protein Binding
16%